DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Levy G, Schmidli H, Punch J. et al.
Safety, tolerability, and efficacy of everolimus in de novo liver transplant recipients: 12- and 36-month results
Liver Transpl 2006; 12: 1640-1648
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.